Cesca Therapeutics CEO Chris Xu's 2019 pay falls 28% to $472K
Cesca Therapeutics reports 2019 executive compensation
By ExecPay News
Published: November 5, 2021
Cesca Therapeutics reported fiscal year 2019 executive compensation information on November 5, 2021.
In 2019, four executives at Cesca Therapeutics received on average a compensation package of $254K, a 23% decrease compared to previous year.
Average pay of disclosed executives at Cesca Therapeutics
Chris Xu, Chief Executive Officer, received $472K in total, which decreased by 28% compared to 2018. 100% of Xu's compensation, or $472K, was in salary.
Jeffery Cauble, Chief Financial Officer, received a compensation package of $222K. 81% of the compensation package, or $179K, was in salary.
Jeff Cauble, Chief Financial Officer, earned $222K in 2019, a 6% increase compared to previous year.
James Xu, General Counsel, received $99K in 2019, which decreases by 24% compared to 2018.
Related executives
You may also like
Source: SEC filing on November 5, 2021.